cTnI/CK-MB/MYO Quantitative Test Kit-心脏疾病诊断
0512-80988088
当前位置:首页 >产品中心 >定量POCT产品 >心脏疾病诊断 心脏疾病诊断

cTnI/CK-MB/MYO Quantitative Test Kit

Time-Resolved Fluorescent Immunochromagraphic Assay

【General Information】

1.Method: Time-resolved Fluorescent Immunochromatographic Method;

2.Bio-marker tested: cardiac troponin I (cTnI), creatine kinase (CK-MB), myoblobin (MYO);

3.Clinical Sample: whole blood, serum or plasma;

4.Other Specifications: in vitro, quantitative test;

【Clinical significance】

1. "Golden Standard" to diagnose myocardial infarction (MI);

2. Assess infarct size and ACS risks;

3. Diagnose reinfarction or infarct extension;

4. Diagnosis of myocardial injury in perioperative period and perinatal period;

5. As myocardial infarction (AMI) early detection indicators, highly sensitive;

6. Diagnose reinfarction or infarct extension;

7. Determine myocardial reperfusion.

【Advantages】

1. Advanced: time-resolved fluorescence immunoassay quantitative chromatography;

2. Quantitative: quantitative detection of cardiac troponin I (cTnI), creatine kinase (CK-MB) and myoblobin (MYO);

3. Accurate: well correlated with imported chemiluminescence reagent (r> 0.975) ;

4. High sensitivity: lower detection limit <0.05 ng/mL (cTnI) , <0.25 ng/mL (CK-MB) and <1.0 ng/mL (MYO);

5. Simple: simple operation, suitable for bedside detection;

6. Widely applicable : outpatient laboratory, emergency laboratory, medical center, cardiology, ICU, and etc;




返回顶部

更早
2016年02月

手持仪器PocRoc 2S获得注册证

2015年10月

再获5个生化项目注册证,光景生化项目达到10项!

2015年07月

获得CE认证

2014年04月

获得4个即时诊断(POCT)产品注册证书

2014年03月

获得5个纳米微球增强生化产品注册证书

2014年02月

获得时间分辨荧光免疫分析仪产品注册证书

2014年01月

何爱民博士入选“国家千人计划创业人才”